- The Medical Travel Company (TMTC) will use the Seed funding to target the “broken” $100bn global medical tourism industry, initially focusing on the UK market
- Lead investor Nexus Venture Partners is joined by international cricketers-turned VCs Ben Stokes, Jofra Archer and KL Rahul, who champion TMTC’s efforts to close a critical gap in patient access
- The Medical Travel Company launches the world’s first post-surgery insurance, protecting patients after returning home from treatment in India.
London, UK, Tuesday October 7th, 2025: The UK and India-based medical travel startup – The Medical Travel Company (TMTC) – has raised 4.5 million USD to bring a new full stack medical solution, offering UK patients world class and affordable treatments in India.
The round has been led by prominent global VC Nexus Venture Partners, with participation from 4CAST, an athlete-led collective and investment group cofounded by England cricket stars Ben Stokes and Jofra Archer and Indian cricketing pro KL Rahul.
Together, they will bring their collective influence and experience of India’s healthcare system to support The Medical Travel Company in its goal: to initially target the UK and create UK-doctor led pathways for patients to access world-class treatment in India at up to 70% lower costs.
As of June 2025, approximately 7.7 million people in the UK face long waits for elective procedures, particularly in orthopaedics, dental, IVF, gynaecology, ophthalmology and urology. With private care in the UK often unaffordable, medical tourism has surged — over 500,000 UK residents now travel abroad annually for faster, more affordable treatment.
However, the $100bn industry has historically struggled with fragmented services, opaque pricing, inconsistent quality standards, and poor aftercare, leaving patients and primary caregivers uncertain, stressed, and sometimes at risk.
The Medical Travel Company was founded by Sahil Jain and Ankit Mehrotra, the duo behind one of India’s most successful consumer-tech stories – Dineout, the restaurant-tech platform that redefined dining in India before its 2022 acquisition by Swiggy for $200 million.
The serial entrepreneurs are solving for the critical gaps in medical travel by providing:
- Trusted UK Medical Oversight: Your own UK doctor remains involved before, during, and after treatment.
- World-Class Clinical Excellence: Treatment from internationally-trained doctors in globally accredited (JCI, NABH) hospitals.
- Unprecedented Peace of Mind: An industry-first, 12-month post-surgery insurance policy valid back in the UK at a network of private hospitals
- Seamless VIP Experience: A fully managed journey with in-house, personalised, all-inclusive after care and concierge logistics.
Sahil Jain, Co-Founder & CEO of The Medical Travel Company, comments: “Medical tourism is a broken industry: patients face fragmented care, hidden costs, and zero support when they return home. The Medical Travel Company ensures true continuity of care across borders: UK doctors overseeing your care from start to finish, all-inclusive rehab and aftercare in India, and post-treatment insurance in the UK. What begins in the UK is only the first chapter of a larger vision to transform cross-border healthcare access across the Western world. Because for us, it’s not medical tourism. It’s healthcare certainty.”
The funds will be used to expand and deepen our clinical partnerships in the UK to strengthen patient trust, establish certified treatment pathways for safer medical travel, and build the technology to maintain complete medical records so patients have continuity of care when they return home.
Pratik Poddar, Partner at Nexus Venture Partners said: “The medical tourism market holds immense untapped value, and The Medical Travel Company’s full-stack model is the key to unlocking it. Having founded one of India’s most successful consumer-tech stories, Sahil, Ankit and their team are uniquely positioned to build trust and capture this opportunity. India has long been a leading medical frontier, with world-class practitioners and cutting-edge technology; it’s about time this excellence is made globally accessible”
Ben Stokes, founder of 4CAST and captain of the England Test team, said: “We are delighted to announce our investment in The Medical Travel Company. When we first started 4CAST in 2021 we wanted our collective of athletes to be able to partner with innovative businesses and great founders. We feel we have done so here and we are excited to back Ankit and Sahil and look forward to supporting their journey ahead with TMTC.”
Jofra Archer, 4CAST cofounder and England bowler, adds: “”From my time playing in the IPL and touring India with England, I’ve always found the medical care and support there to be excellent. We invested because The Medical Travel Company is building a proper bridge for patients, with transparency and professional oversight that really gives peace of mind””
